COMPANY
SHANDONG NEW TIME PHARMACEUTICAL CO LTD
SHANDONG NEW TIME PHARMACEUTICAL CO LTD: API manufacturer, trial sponsor for Carfilzomib, Semaglutide, as stated by public registers.
Also written as: Shandong New Time Pharmaceutical Co., LTD.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Carfilzomib | DMF 38290, type II, active, submitted 2023-05-16 Regulator FDA drug master file list |
|---|
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Semaglutide | 1 registered trial Trial register ClinicalTrials.gov |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.